- Home
- JAGX
JAGX
Jaguar Health Inc.
as 07-26-2024 4:00pm EST
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.
| Founded: | 2013 | Country: | United States |
| Employees: | N/A | City: | SAN FRANCISCO |
| Market Cap: | 18.5M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 1.4M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -26.40 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.25 - $39.60 | Next Earning Date: | 08-12-2024 |
| Revenue: | $10,140,000 | Revenue Growth: | -10.29% |
| Revenue Growth (this year): | 57.85% | Revenue Growth (next year): | 50.01% |
Latest Jaguar Health Inc. News
JAGX Breaking Stock News: Dive into JAGX Ticker-Specific Updates for Smart Investing
MT Newswires
3 days ago
Top Midday Decliners
MT Newswires
3 days ago
Sector Update: Health Care Stocks Advance in Afternoon Trading
MT Newswires
3 days ago
Jaguar Health Shares Plunge After Cancer Therapy-Related Diarrhea Treatment Fails to Meet Primary Goal
Clinical Trials Arena
3 days ago
Jaguar Health shares slump following Phase III Mytesi failure
ACCESSWIRE
3 days ago
Jaguar Health Reports Phase 3 OnTarget Trial Results for its Cancer Supportive Care Drug Crofelemer
ACCESSWIRE
8 days ago
Jaguar Health to Report Phase 3 OnTarget Trial Results for Its Cancer Supportive Care Drug Crofelemer on July 23rd and Hold Investor Webcast that Morning
MT Newswires
18 days ago
Jaguar Health Unit Secures New European, Australian Patents; Shares Rise
ACCESSWIRE
a month ago
Jaguar Health Regains Compliance with Nasdaq's Bid Price Requirement
Compare JAGX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "JAGX Jaguar Health Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.